December 2016: Annual Mammogram comes back normal.
April 7, 2017: Annual MRI. Nodule spotted in right breast. Ultrasound and vacuum biopsy performed. Biopsy says nodule is at 6 o’clock axis 4 cm from nipple measuring 5.5mm.
April 11, 2017: Diagnosed Infiltrating Lobular Carcinoma. 0.5cm tumor. ER positive, PR negative, HER status unknown. KI-67 10% (low). Grade 2 (out of 3).
April 17, 2017: Revised pathology diagnoses me as Invasive Ductal Carcinoma. 0.5cm tumor. ER positive, PR positive (weak). HER negative. KI-67 20% (high). Grade 2 (out of 3). Lab: University of Florida/Palm Beach Radiology
April 25, 2017: Mammogram and Ultrasound performed at MD Anderson. Nothing is spotted in right breast except hematoma from biopsy and clip that was inserted from biopsy. Report says mass may be “obscured by post-biopsy changes”. Lesion is spotted in my other (left) breast. 6:00 position, 4 cm from nipple. No suspicious findings in lymph nodes.
April 26, 2017: Ultrasound needle biopsy on left breast performed at MD Anderson. Results are benign.
May 30: Pre-Op, MD Anderson. Bloodwork, EKG and chest X-ray
June 6: Skin sparring bi-lateral mastectomy with reconstruction (tissue expanders), MD Anderson
June 19: First fill for tissue expanders
June 20: Final diagnosis of Invasive Ductal Carcinoma, Stage 1b. Original tumor was 0.5cm, only o.1cm was found during surgery (the rest of the tumor was removed during biopsy). No lymph node involvement. Recommended treatment is 5 years of taking the hormone blocking drug, Arimidex.
June 21: Started taking Arimidex.
September 19: Surgery to exchange tissue expanders to implants.